The Michigan Department of Licensing and Regulatory Affairs (LARA) released a notice on Sept. 22 to all prescribers and stakeholders impacted by the state’s e-prescription law that is going into effect on Oct. 1, 2021. The notice stated that the law would still go into effect on Oct. 1, but enforcement of the mandate will be delayed until Jan. 1, 2022, to coincide with federal enforcement. LARA also stated that the rules for the state mandate, including eligibility for a waiver, remain in development.
This change does not impact the MDA’s advice to members, which is to take the necessary steps to come into compliance as soon as possible.
- If you have already signed up for e-prescription software, there is nothing else you need to do. If you are in the process of doing so, this notice ensures you will not face any consequences as long as you are in compliance by Jan. 1, 2022.
- If you have not started the process of signing up for an e-prescription software, it is imperative that you do so now. There are multiple options available. You can learn more about iCoreRx, endorsed by the MDA, at icoreconnect.com/MDA or by calling 888-810-7706.
The MDA advocacy team advocated for a delay in enforcement of this requirement until the rules were clear. The MDA will continue to apprise LARA of the impact that this law has on members and will keep you informed of further updates on this issue.
If you have any additional questions, email the MDA’s Neema Katibai, manager of government and insurance affairs, or call 517-346-9422. Or visit the ePrescriptions page on the MDA website for more information.